phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Blood Marker Shows Promise for Tracking Oxaliplatin-Related Nerve Damage

A research team has found preliminary evidence that a blood-based marker of nerve injury could help researchers track peripheral neurotoxicity caused by oxaliplatin, a chemotherapy drug used to treat colorectal cancer. In a study of 28 patients, serum neurofilament light chain (sNfL) increased during treatment and remained elevated three months afterward, alongside worsening neuropathy assessments. Higher follow-up concentrations were associated with more severe clinical signs and patient-reported symptoms. The findings suggest that sNfL could complement existing assessments in trials evaluating interventions to prevent chemotherapy-related nerve damage, providing an objective measure of changes in nerve injury.

November 9, 2026


November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026

November 3 2026

November 2 2026

November 1 2026

October 30 2026

October 29 2026

October 28 2026

October 27 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy